Elevance Health | ANTM - Ebitda

Aktienkurs
376.42
Täglich Wechseln
-0.21 -0.06%
Monatlich
28.58%
Jährlich
-7.81%
Q2 Prognose
337.38




Ebitda Veränderung Datum
Acadia Healthcare USD 144.22M 44.37M 2026-03
Addus HomeCare USD 50.34M 5.19M 2025-12
Brookdale Senior Living USD 105.56M 5.51M 2025-12
Cardinal Health USD 1.09B 109M 2026-03
Centene USD 2.56B 3.47B 2026-03
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cigna USD 2.86B 56M 2025-03
Community Health Systems USD 395M 19M 2025-12
CVS Health USD 3.74B 349M 2025-12
DaVita Healthcare Partners USD 772.7M 89.45M 2025-12
Elevance Health USD 4.21B 2.02B 2026-03
Encompass Health USD 335.6M 35.5M 2025-12
Ensign USD 159.76M 8.67M 2025-12
HCA USD 3.8B 312M 2026-03
Humana USD 2.06B 2.35B 2026-03
IQVIA Holdings USD 1.05B 97M 2025-12
Laboratory Of America USD 605.6M 17.5M 2026-03
McKesson USD 1.68B 418M 2025-09
Molina Healthcare USD 267M 385M 2026-03
Pediatrix Medical Group USD 65.84M 21.47M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Select Medical USD 100.14M 11.51M 2025-12
Tenet Healthcare USD 1.16B 21M 2026-03
UnitedHealth USD 9.99B 8.5B 2026-03
Universal Health Services USD 678.67M 8.07M 2025-12
Veradigm USD 38.81M 29.61M 2022-09